Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 7,110 shares at $104.81 ($749K) on 2018-05-16, disclosed to the SEC on 2018-05-18.
Open-market sale of $749k ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.85 | 400 | $42K | 5.5% |
| 2 | $104.81 | 800 | $84K | 11.2% |
| 3 | $105.57 | 2,955 | $312K | 41.6% |
| 4 | $105.57 | 2,955 | $312K | 41.6% |
| Total | $105.39 avg | 7,110 | $749K | 100% |
| Filing → |
| ENTA | SELL | 2022-01-13 | $1.8M | — | Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |